Literature DB >> 35220547

Eco-friendly and regiospecific intramolecular cyclization reactions of cyano and carbonyl groups in N,N-disubstituted cyanamide.

Amr H Moustafa1, Walaa W Ahmed2, Mohamed F Awad3, Moustafa O Aboelez4, Ahmed Khodairy2, Amer A Amer2.   

Abstract

Eco-friendly, low-cost and high-yielding synthetic route toward imidazoles and oxazoles has been developed. 1-(4,6-Dimethylpyrimidin-2-yl)-2-(alkylamino)-1,5-dihydro-4H-imidazol-4-one 3a-c have been synthesized via regiospecific reaction of ethyl 2-(N-(4,6-dimethylpyrimidin-2-yl)cyanamide)acetate 1 with primary aliphatic amines in water as green solvent. While, the reaction between 4,6-dimethylpyrimidin-2-yl(2-oxo-2-phenylethyl)cyanamide 2 and primary aliphatic amines using water and/or iso-propanol as green solvents afforded 3-(4,6-dimethylpyrimidin-2-yl)-5-phenyl-1,3-oxazole-2(3H)-imine 6 and 1-(4,6-dimethylpyrimidin-2-yl)-N-alkyl-4-phenyl-1H-imidazol-2-amine 7a-d, respectively.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Eco-friendly reaction; Imidazole; Intramolecular cyclization; N-(4,6-Dimethylpyrimidin-2-yl)cyanamide; Oxazole; Regiospecificity

Mesh:

Substances:

Year:  2022        PMID: 35220547     DOI: 10.1007/s11030-022-10401-z

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  15 in total

1.  Green chemistry oriented organic synthesis in water.

Authors:  Marc-Olivier Simon; Chao-Jun Li
Journal:  Chem Soc Rev       Date:  2011-11-02       Impact factor: 54.564

2.  Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.

Authors:  C B Pradeep Kumar; B S Prathibha; K N N Prasad; M S Raghu; M K Prashanth; B K Jayanna; Fahad A Alharthi; S Chandrasekhar; H D Revanasiddappa; K Yogesh Kumar
Journal:  Bioorg Med Chem Lett       Date:  2021-01-19       Impact factor: 2.823

3.  Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.

Authors:  Drashti G Daraji; Dhanji P Rajani; Smita D Rajani; Edwin A Pithawala; Sivaraman Jayanthi; Hitesh D Patel
Journal:  Bioorg Med Chem Lett       Date:  2021-01-26       Impact factor: 2.823

4.  Synthesis and antifungal activity of novel streptochlorin analogues.

Authors:  Ming-Zhi Zhang; Qiong Chen; Cai-Hong Xie; Nick Mulholland; Sarah Turner; Dianne Irwin; Yu-Cheng Gu; Guang-Fu Yang; John Clough
Journal:  Eur J Med Chem       Date:  2015-01-22       Impact factor: 6.514

5.  Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Einhibitors.

Authors:  Eslam M H Ali; Mohammed S Abdel-Maksoud; Usama M Ammar; Karim I Mersal; Kyung Ho Yoo; Park Jooryeong; Chang-Hyun Oh
Journal:  Bioorg Chem       Date:  2020-11-24       Impact factor: 5.275

6.  Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands.

Authors:  Arun K Ghosh; Jun Takayama; Luke A Kassekert; Jean-Rene Ella-Menye; Sofiya Yashchuk; Johnson Agniswamy; Yuan-Fang Wang; Manabu Aoki; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  Bioorg Med Chem Lett       Date:  2015-05-30       Impact factor: 2.823

7.  Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists.

Authors:  Robert J Gleave; Daryl S Walter; Paul J Beswick; Elena Fonfria; Anton D Michel; Shilina A Roman; Sac-Pham Tang
Journal:  Bioorg Med Chem Lett       Date:  2010-06-25       Impact factor: 2.823

8.  Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.

Authors:  Dongsheng Li; Nana Gao; Ningyu Zhu; Yuan Lin; Yan Li; Minghua Chen; Xuefu You; Yu Lu; Kanglin Wan; Jian-Dong Jiang; Wei Jiang; Shuyi Si
Journal:  Bioorg Med Chem Lett       Date:  2015-10-01       Impact factor: 2.823

9.  Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity.

Authors:  Naglaa M Ahmed; Mahmoud M Youns; Moustafa K Soltan; Ahmed M Said
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

10.  Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.

Authors:  Daniel G Silva; Anna Junker; Shaiani M G de Melo; Fernando Fumagalli; J Robert Gillespie; Nora Molasky; Frederick S Buckner; An Matheeussen; Guy Caljon; Louis Maes; Flavio S Emery
Journal:  ChemMedChem       Date:  2020-11-11       Impact factor: 3.466

View more
  4 in total

1.  Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M.

Authors:  Moustafa O Aboelez; Amany Belal; Guangya Xiang; Xiang Ma
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management.

Authors:  Amany Belal; Mohamed A Elanany; Eman Y Santali; Ahmed A Al-Karmalawy; Moustafa O Aboelez; Ali H Amin; Magda H Abdellattif; Ahmed B M Mehany; Hazem Elkady
Journal:  Molecules       Date:  2022-06-02       Impact factor: 4.927

3.  Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Bakheet E M Elsadek; Hatem A Sarhan; Khaled Ali Khaled; Amany Belal; Ahmed Khames; Yasser A Hassan; Amany A Abdel-Rheem; Eslam B Elkaeed; Mohamed Raafat; Mahmoud Elkot Mostafa Elsadek
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

4.  Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.

Authors:  Mahmoud M A Elsayed; Moustafa O Aboelez; Mohamed S Mohamed; Reda A Mahmoud; Ahmed A El-Shenawy; Essam A Mahmoud; Ahmed A Al-Karmalawy; Eman Y Santali; Sameer Alshehri; Mahmoud Elkot Mostafa Elsadek; Mohamed A El Hamd; Abd El Hakim Ramadan
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.